Ledger.Open graph →
SEC Form D · filed September 29, 2021

Black Swan Pharmaceuticals, Inc

Offering
$3.0M
Sold
$1.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WAKE FOREST, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Om Dhingra · Wake Forest, NCDirectorSteve Arnott · Wake Forest, NCDirectorAnthony Akkari · Wake Forest, NCDirectorCraig Metz · Wake Forest, NCExec · DirectorJerod Bowen · Chandler, AZDirectorGrant Thompson · New Market, MDDirectorMary E. Alexander · Fayetteville, ARExec · DirectorStephen C. Malloy · Fayetteville, ARDirectorJulian Arbuckle · Wake Forest, NCDirectorJay Posner · MILL VALLEY, CAExec · DirectorTony Fenner-Leitao · MILL VALLEY, CADirectorKaren W. Mcmonagle · New York, NYDirectorBrian Barlow · Brooklyn, NYDirectorJulian Arbuckle · Wake Forest, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗